Practical aspects of multiple sequence alignment.

A. D. Baxevanis

DOI: https://doi.org/10.1002/9780470110607.CH8

Abstract:

What problem does this paper attempt to address?

[Use of Laser Capture Microdissection and Surface-Enhanced Laser Desorption Ionization Time-of-flight Mass Spectrometry to Screen Differential Proteins in Lung Adenocarcinoma and Lung Squamous Carcinoma].

Ying-Xuan Tian,Shuan-Ying Yang,Yan-Dong Nan,Wei Zhang,Bin Zhou,Li-Na Bu,Shu-Fen Huo,Jie-Kai Yu,Shu Zheng

DOI: https://doi.org/10.3321/j.issn:0376-2491.2008.03.001

2008-01-01

Abstract:OBJECTIVE:To screen biomarkers for classification in lung adenocarcinoma and lung squamous carcinoma by using laser capture microdissection (LCM) and surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS) and support vector machine (SVM).METHODS:Six specimens of lung adenocarcinoma tissues and seven specimens of lung squamous carcinoma tissues obtained during operation were made into frozen sections and stained by improved H-E solution. About 1.2 x 10(5) of homogeneous adenocarcinoma cells and 1.4 x 10(5) of homogeneous lung squamous carcinoma cells were collected using LCM. Then SELDI profiles based on PBS II(+)SELDI-TOF-MS (IMAC protein chip) and the data were analyzed by support vector machine (SVM).RESULTS:Eighty seven differential protein peaks were found and top ten of them were identified as candidate biomarkers. The expression levels of 6 proteins among them with the molecular weights of 3333, 3592, 3848, 5036, 5191, and 5211 respectively in the lung squamous cancer tissues were weaker than those in the adenocarcinoma tissues, and the expression levels of 4 proteins with the molecular weights of 2505, 4004, 4847, and 11 412 in the lung squamous carcinoma tissues were stronger than those in the adenocarcinoma tissues. The expression of the protein with the molecular weight of 4847 in the squamous cancer was significantly stronger than that in the adenocarcinoma (p + 0.032). A discriminatory pattern consisting of 3 proteins with the molecular weights of 4847, 11 412, and 3592 was established with a sensitivity of 100% and a specificity of 100% respectively in separating adenocarcinoma from squamous carcinoma.CONCLUSION:There is a difference in protein component between adenocarcinoma and squamous carcinoma. LCM combined with SELDI-TOF-MS help screen a biomarker pattern to distinguish lung adenocarcinoma from lung squamous carcinoma with high sensitivity and specificity.
Proteomic and Phosphoproteomic Maps of Lung Squamous Cell Carcinoma from Chinese Patients.

Lulu Pan,Xijun Wang,Longhai Yang,Lei Zhao,Linhui Zhai,Junyu Xu,Yikun Yang,Yousheng Mao,Shujun Cheng,Ting Xiao,Minjia Tan

DOI: https://doi.org/10.3389/fonc.2020.00963

IF: 4.7

2020-01-01

Frontiers in Oncology

Abstract:Lung squamous cell carcinoma (LUSC) is one of the leading causes of tumor-driven deaths in the world. To date, studies on the tumor heterogeneity of LUSC at genomic level have only revealed limited therapeutic benefits. Therefore, system-wide research of LUSC at proteomic level may further improve precision medicine strategies on individual demands. To this end, we performed proteomic and phosphoproteomic study for LUSC samples of 25 Chinese patients. From our results, two subgroups (Cluster I and II) based on proteomic data were identified, which were associated with distinct molecular characteristics and clinicopathologic features. Combined with phosphoproteomic data, our result showed that spliceosome pathway was enriched in Cluster I, while focal adhesion pathway, immune-related pathways and Ras signaling pathway were enriched in Cluster II. In addition, we found that lymph node metastasis (LNM) was associated with our proteomic subgroups and cell cycle pathway was enriched in patients with LNM. Further analysis showed that MCM2, a DNA replication licensing factor involved in cell cycle pathway, was highly expressed in patients with poor prognosis, which was further proved by immunohistochemistry (IHC) analysis. In summary, our study provided a resource of the proteomic and phosphoproteomic features of LUSC in Chinese patients.
Interactive Verification Analysis of Multiple Sequencing Data for Identifying Potential Biomarker of Lung Adenocarcinoma

Hongjun Fei,Songchang Chen,Chenming Xu

DOI: https://doi.org/10.1155/2020/8931419

2020-01-01

BioMed Research International

Abstract:Background. Lung adenocarcinoma (LUAD) comprises around 40% of all lung cancers, and in about 70% of patients, it has spread locally or systemically when first detected leading to a worse prognosis. Methods. We filtered out differentially expressed genes (DEGs) based on the RNA sequencing data in the Gene Expression Omnibus database and verified and deeply analyzed screened DEGs using a combined bioinformatics approach. Results. Expressions of 11,143 genes in 694 nontumor lung tissues and LUAD cases from 8 independent laboratories were analyzed; 188 mRNAs were identified as differentially expressed genes (DEGs). A PPI network constructed with 188 DEGs screened out 8 hub DEGs (CDH5, PECAM1, VWF, CLDN5, COL1A1, MMP9, SPP1, and IL6) which highly interconnected with other nodes. The expression levels of 8 hub genes in LUAD and control were assessed in the Oncomine database, and the results were consistent. The survival curves of 8 hub genes showed that their expressions are significantly related to the prognosis of lung cancer and LUAD patients except forIL6. Since the expression of IL6 is nonspecific and highly sensitive, we choose the other 7 hub genes we had verified to do the next analysis. Mutual exclusivity or cooccurrence analysis of 7 hub genes identified a tendency towards cooccurrence between CDH5, PECAM1, and VWF in LUAD. The coexpression profiles of CDH5 in LUAD were identified, and we found that PECAM1 and VWF coexpressed with CDH5. Immunohistochemistry and RT-PCR analysis showed that higher levels of CDH5, PECAM1, and VWF were expressed in normal lung tissues but a low or undetectable level was found in LUAD tissues. Conclusions. Taken together, we speculate that CDH5, PECAM1, and VWF played an important role in LUAD.
Identification of Key Genes and Evaluation of Clinical Outcomes in Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis

Yangfeng Shi,Yeping Li,Chao Yan,Hua Su,Kejing Ying

DOI: https://doi.org/10.3892/ol.2019.10933

2019-01-01

Oncology Letters

Abstract:Lung cancer is the leading cause of cancer-related mortality worldwide. Despite progress in the treatment of non-small-cell lung cancer, there are limited treatment options for lung squamous cell carcinoma (LUSC), compared with lung adenocarcinoma. The present study investigated the disease mechanism of LUSC in order to identify key candidate genes for diagnosis and therapy. A total of three gene expression profiles (GSE19188, GSE21933 and GSE74706) were analyzed using GEO2R to identify common differentially expressed genes (DEGs). The DEGs were then investigated using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis. A protein-protein interaction (PPI) network was constructed via the Search Tool for the Retrieval of Interacting Genes/Proteins, and visualized using Cytoscape software. The expression levels of the hub genes identified using CytoHubba were validated using the University of California, Santa Cruz (UCSC) database and the Human Protein Atlas. A Kaplan-Meier curve and Gene Expression Profiling Interactive Analysis were then employed to evaluate the associated prognosis and clinical pathological stage of the hub genes. Furthermore, non-coding RNA regulatory networks were constructed using the Gene-Cloud Biotechnology information website. A total of 359 common DEGs (155 upregulated and 204 downregulated) were identified, which were predominantly enriched in ‘mitotic nuclear division’, ‘cell division’, ‘cell cycle’ and ‘p53 signaling pathway’. The PPI network consisted of 257 nodes and 2,772 edges, and the most significant module consisted of 66 upregulated genes. A total of 19 hub genes exhibited elevated RNA levels, and 10 hub genes had elevated protein levels compared with normal lung tissues. The upregulation of five hub genes (CCNB1, CEP55, FOXM1, MKI67 and TYMS; defined in Table I) were significantly associated with poor overall survival and unfavorable clinical pathological stages. Various ncRNAs, such as C1orf220, LINC01561 and MGC39584, may also play important roles in hub-gene regulation. In conclusion, the present study provides further understanding of the pathogenesis of LUSC, and reveals CCNB1, CEP55, FOXM1, MKI67 and TYMS as potential biomarkers or therapeutic targets.
Relative Protein Quantification and Accessible Biology in Lung Tumor Proteomes from Four LC-MS/MS Discovery Platforms

Paul A. Stewart,Bin Fang,Robbert J. C. Slebos,Guolin Zhang,Adam L. Borne,Katherine Fellows,Jamie K. Teer,Y. Ann Chen,Eric Welsh,Steven A. Eschrich,Eric B. Haura,John M. Koomen

DOI: https://doi.org/10.1002/pmic.201600300

2017-01-01

PROTEOMICS

Abstract:Discovery proteomics experiments include many options for sample preparation and MS data acquisition, which are capable of creating datasets for quantifying thousands of proteins. To define a strategy that would produce a dataset with sufficient content while optimizing required resources, we compared (1) single-sample LC-MS/MS with data-dependent acquisition to single-sample LC-MS/MS with data-independent acquisition and (2) peptide fractionation with label-free (LF) quantification to peptide fractionation with relative quantification of chemically labeled peptides (sixplex tandem mass tags (TMT)). These strategies were applied to the same set of four frozen lung squamous cell carcinomas and four adjacent tissues, and the overall outcomes of each experiment were assessed. We identified 6656 unique protein groups with LF, 5535 using TMT, 3409 proteins from single-sample analysis with data-independent acquisition, and 2219 proteins from single-sample analysis with data-dependent acquisition. Pathway analysis indicated the number of proteins per pathway was proportional to the total protein identifications from each method, suggesting limited biological bias between experiments. The results suggest the use of single-sample experiments as a rapid tissue assessment tool and digestion quality control or as a technique to maximize output from limited samples and use of TMT or LF quantification as methods for larger amounts of tumor tissue with the selection being driven mainly by instrument time limitations. Data are available via ProteomeXchange with identifiers PXD004682, PXD004683, PXD004684, and PXD005733.
Proteomic profiles of human lung adeno and squamous cell carcinoma using super-SILAC and label-free quantification approaches

Wen Zhang,Yuhong Wei,Vladimir Ignatchenko,Lei Li,Shingo Sakashita,Nhu-An Pham,Paul Taylor,Ming Sound Tsao,Thomas Kislinger,Michael F Moran

DOI: https://doi.org/10.1002/pmic.201300382

PROTEOMICS

Abstract:Nonsmall cell lung cancer (NSCLC) accounts for 85% of lung cancers, and is subdivided into two major histological subtypes: adenocarcinoma (ADC) and squamous cell carcinoma (SCC). There is an unmet need to further subdivide NSCLC according to distinctive molecular features that may be associated with responsiveness to therapies. Four primary tumor-derived xenograft proteomes (two-each ADC and SCC) were quantitatively compared by using a super-SILAC labeling approach together with ultrahigh-resolution MS. Proteins highly differentially expressed in the two subtypes were identified, including 30 that were validated in an independent cohort of 12 NSCLC primary tumor-derived xenograft tumors whose proteomes were quantified by an alternative, label-free shotgun MS methodology. The 30-protein signature contains metabolism enzymes including phosphoglycerate dehydrogenase, which is more highly expressed in SCC, as well as a comprehensive set of cytokeratins and other components of the epithelial barrier, which is therefore distinctly different between ADC and SCC. These results demonstrate the utility of the super-SILAC method for the characterization of primary tissues, and compatibility with datasets derived from different MS-based platforms. The validation of proteome signatures of NSCLC subtypes supports the further development and application of MS-based quantitative proteomics as a basis for precision classifications and treatments of tumors. All MS data have been deposited in the ProteomeXchange with identifier PXD000438 (http://proteomecentral.proteomexchange.org/dataset/PXD000438).
A Bird's Eye View of Quantitative Proteome of Tumor Tissues from Lung Cancer Patients by a High Precision Mass Spectrometry Method

Wang, Qi,You, Xin

DOI: https://doi.org/10.1007/s40242-024-3246-y

IF: 3.1

2024-01-13

Chemical Research in Chinese Universities

Abstract:Lung cancer produces a high incidence of malignant tumors. There have been many studies on lung cancer using mass spectrometry (MS) technologies. However, most studies have focused on humoral samples. In this work, 26 pairs of tissue samples (tumor vs. para-tumor) from patients with lung cancer were analyzed using liquid chromatography-tandem MS (LC-MS/MS) with data-independent acquisition mode. In total, 3152 proteins were quantified from tissue samples with high confidence, including 189 up-regulated and 522 down-regulated proteins (tumor vs. para-tumor). In addition, 79 and 690 proteins were identified only in para-cancerous samples and cancerous samples, respectively. The results from bio-informatics tools indicated that altered proteins like PEBP1, HRG and LYZ could be ideal reservoirs for screening the potential biomarkers for lung cancer. It is believed these tissue-specific proteomics results will assist in the studies of lung cancer.

chemistry, multidisciplinary
Comparative proteome analysis of human lung squamous cell carcinoma

Can-E Tang,Cui Li,Zhi-Qiang Xiao,Xiao-Peng Zhang,Zhuchu Chen,Hong Yi,Jian-Ling Li,Chao-jun Duan,Songping Liang

2006-01-01

Abstract:Objective This study was designed to establish the two-dimensional electrophoresis profiles with high resolution and reproducibility from human lung squamous cell carcinoma tissue and paired tumor-adjacent normal bronchial epithelial tissue, and to identify differential expression of tumor-associated proteins by using proteome analysis. Methods Comparative proteome analysis of human lung squamous carcinoma and paired normal bronchial mucosa adjacent to tumors from 20 cases were carried out. Total proteins of the carcinoma tissue and normal bronchial mucosa were seperated by means of immobilized pH gradient-based two-dimensional gel electrophoresis （2-DE）. The differentially expressed proteins were analyzed and identified by matrix-assisted laser desorption/ionization time of flight mass spectrometry （MALDI-TOF-MS）. Results （1） Seventy-six differentially expressed proteins were screened by analyzing the electrophoretic maps of the 20 carcinoma and control mucosa tissues. （2） Sixty-eight differential proteins were identified by peptide mass fingerprinting （PMF）. Some proteins were products of oncogenes and others were involved in the regulation of cell cycle and signal transduction. （ 3 ） The expression of three proteins mdm2, c-Jun and EGFR, correlated with lung squamous carcinoma, were detected by immunohistochemical staining and Western blot analysis. The results showed that the expression of mdm2, c-Jun and EGFR were up-regulated in lung squamous carcinomas, whereas down-regulated in control normal mucosa. It was consistent with our proteome analysis results. Those results suggested that those proteins may play roles in the carcinogenesis of lung squamous carcinoma. Conclusion sixty-eight differentially expressed proteins were successfully characterized by comparative proteome analysis. Those results may provide scientific foundation for screening the molecular biomarkers which can be used in diagnosis and treatment of lung squamous carcinoma, as well as to improve patients＇ prognosis and provide a new clue for carcinogenesis research of lung squamous cell carcinoma. Key words: Lung squamous cell carcinoma; Proteome analysis; Bronchial epithelial tissue; Differential proteins expression
Differential mitochondrial proteome analysis of human lung adenocarcinoma and normal bronchial epithelium cell lines using quantitative mass spectrometry

Wei Zhang,Yanting Li,Shuanying Yang,Wei Li,Zongjuan Ming,Yuping Zhang,Yanli Hou,Zequn Niu,Biaoxue Rong,Xuede Zhang,Xiaoli Liu

DOI: https://doi.org/10.1111/1759-7714.12031

IF: 3.223

2013-10-27

Thoracic Cancer

Abstract:BACKGROUND: Lung cancer is one of the higher incidences of malignant tumors around the world. At present, tumor markers CEA, CA19-9, and CA-125 in serum are used for the diagnosis of lung cancer, however, fewer studies have shown tumor markers for early diagnosis. Therefore, using quantitative mass spectrometry, differential mitochondrial proteome analysis was performed, comparing human lung adenocarcinoma and normal bronchial epithelium cells.METHODS: A human lung adenocarcinoma cell line A549 and a normal human bronchial epithelial cell line 16HBE were cultured in vitro. The cell mitochondria of the two cell lines were extracted and purified by differential centrifugation and percoll density gradient centrifugation. The integrity and purity of mitochondria were validated by electron microscopy and Western-blot. The proteins/peptides from lung cancer cells and normal cells were marked by the same amount of relative and absolute quantification of ectopic tags (iTRAQ). The mixed samples were analyzed and identified by two-dimensional liquid chromatography - tandem mass spectrometry (2D-LC-MS/MS). The proteome was analyzed with different bioinformatic tools.RESULTS: One hundred and sixty-one mitochondrial proteins were identified. One hundred and fifty-three mitochondrial proteins, which were expressed differently between 16HBE cells and A549 cells, were identified. Sixty-seven proteins were high expression, while 86 proteins were lower expression. Expression of three proteins: ornithine aminotransferase (OAT), heat shock protein beta90 (HSP90), and vimentin (VIM), was increased more than twice. Our results, in combination with the literature review, suggest that HSP90 and Vimentin may be the new tumor markers of lung cancer.

oncology,respiratory system
Profiling differentially expressed proteins in lung adenocarcinoma by label-free proteomics

邱满堂,祖桂利,姜冠潮

DOI: https://doi.org/10.3760/cma.j.cn421213-20200310-01086

2020-01-01

Abstract:Objective:This study was designed to profile protein expression in lung adenocarcinoma by label-free proteomics.Methods:Five treatment-na?ve lung adenocarcinoma patients were retrospectively selected, and total protein was extracted from the paired tumor tissues and adjacent normal tissues. The proteins were analyzed by high performance liquid chromatography-mass spectrometry. The raw data of mass spectrometry was blast to database and quantitatively analyzed by MaxQuant software. After blast to database, the MaxQuant generated data were analyzed by Perseus software. The differentially expressed proteins were further subjected to Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways enrichment analyses. P value<0.05 was considered as statistically significant. Results:After blast to database, we achieved 11295 unique peptides belonging to 908 proteins. A total of 312 proteins were statistically differentially expressed in lung adenocarcinoma compared with adjacent tissues, and 110 proteins were upregulated, and 212 proteins were downregulated in lung adenocarcinoma. The ferritin was most upregulated in lung adenocarcinoma and collagen alpha-3 (VI) chain was most downregulated in lung adenocarcinoma. GO molecular function enrichment analyses showed that the differentially expressed proteins were enriched with function of poly (A) RNA binding and RNA binding.Conclusion:By the label-free proteomics approach, we identified 312 differentially expressed proteins in lung adenocarcinoma.
Abstraction of nano copper in a room temperature ionic liquid

C. Peng,H. -. Wang,C. Huang,Yu-Ling Wei

DOI: https://doi.org/10.1063/1.2644665

2007-02-02

Abstract:Speciation of copper in the abstraction of nano copper with a room temperature ionic liquid (RTIL) (1‐butyl‐3‐methylimidazolium hexafluorophosphate [C4mim][PF6]) has been studied by X‐ray absorption near edge structural (XANES) and extended X‐ray absorption fine structural (EXAFS) spectroscopies in the present work. The least‐square fits of the XANES spectra suggest that nano CuO (79%) and Cu(II) complex (Cu(II)‐IL) (21%) are the main copper species in the RTIL. The fitted EXAFS spectra show that the Cu‐O (1st shell) bond distance is 2.08 A with a coordination number (CN) of 2.6. In the second shells of copper, the average bond distance of Cu‐Cu is 2.99 A with a CN of 5.1.
Proteomic analysis enables distinction of early- versus advanced-stage lung adenocarcinomas

Olga Kelemen,Indira Pla,Aniel Sanchez,Melinda Rezeli,Attila Marcell Szasz,Johan Malm,Viktoria Laszlo,Ho Jeong Kwon,Balazs Dome,Gyorgy Marko-Varga

DOI: https://doi.org/10.1002/ctm2.106

Abstract:Background: A gel-free proteomic approach was utilized to perform in-depth tissue protein profiling of lung adenocarcinoma (ADC) and normal lung tissues from early and advanced stages of the disease. The long-term goal of this study is to generate a large-scale, label-free proteomics dataset from histologically well-classified lung ADC that can be used to increase further our understanding of disease progression and aid in identifying novel biomarkers. Methods and results: Cases of early-stage (I-II) and advanced-stage (III-IV) lung ADCs were selected and paired with normal lung tissues from 22 patients. The histologically and clinically stratified human primary lung ADCs were analyzed by liquid chromatography-tandem mass spectrometry. From the analysis of ADC and normal specimens, 4863 protein groups were identified. To examine the protein expression profile of ADC, a peak area-based quantitation method was used. In early- and advanced-stage ADC, 365 and 366 proteins were differentially expressed, respectively, between normal and tumor tissues (adjusted P-value < .01, fold change ≥ 4). A total of 155 proteins were dysregulated between early- and advanced-stage ADCs and 18 were suggested as early-specific stage ADC. In silico functional analysis of the upregulated proteins in both tumor groups revealed that most of the enriched pathways are involved in mRNA metabolism. Furthermore, the most overrepresented pathways in the proteins that were unique to ADC are related to mRNA metabolic processes. Conclusions: Further analysis of these data may provide an insight into the molecular pathways involved in disease etiology and may lead to the identification of biomarker candidates and potential targets for therapy. Our study provides potential diagnostic biomarkers for lung ADC and novel stage-specific drug targets for rational intervention.
Aberrant Expression of Proteins Involved in Signal Transduction and DNA Repair Pathways in Lung Cancer and Their Association with Clinical Parameters.

Yong He,Zhen Zhou,Wayne L. Hofstetter,Yanbin Zhou,Wenxian Hu,Chengcheng Guo,Li Wang,Wei Guo,Apar Pataer,Arlene M. Correa,Yiling Lu,Jing Wang,Lixia Diao,Lauren Averett Byers,Ignacio I. Wistuba,Jack A. Roth,Stephen G. Swisher,John V. Heymach,Bingliang Fang

DOI: https://doi.org/10.1371/journal.pone.0031087

IF: 3.7

2012-01-01

PLoS ONE

Abstract:BACKGROUND:Because cell signaling and cell metabolic pathways are executed through proteins, protein signatures in primary tumors are useful for identifying key nodes in signaling networks whose alteration is associated with malignancy and/or clinical outcomes. This study aimed to determine protein signatures in primary lung cancer tissues.METHODOLOGY/ PRINCIPAL FINDINGS:We analyzed 126 proteins and/or protein phosphorylation sites in case-matched normal and tumor samples from 101 lung cancer patients with reverse-phase protein array (RPPA) assay. The results showed that 18 molecules were significantly different (p<0.05) by at least 30% between normal and tumor tissues. Most of those molecules play roles in cell proliferation, DNA repair, signal transduction and lipid metabolism, or function as cell surface/matrix proteins. We also validated RPPA results by Western blot and/or immunohistochemical analyses for some of those molecules. Statistical analyses showed that Ku80 levels were significantly higher in tumors of nonsmokers than in those of smokers. Cyclin B1 levels were significantly overexpressed in poorly differentiated tumors while Cox2 levels were significantly overexpressed in neuroendocrinal tumors. A high level of Stat5 is associated with favorable survival outcome for patients treated with surgery.CONCLUSIONS/ SIGNIFICANCE:Our results revealed that some molecules involved in DNA damage/repair, signal transductions, lipid metabolism, and cell proliferation were drastically aberrant in lung cancer tissues, and Stat5 may serve a molecular marker for prognosis of lung cancers.
Comparative proteomic study for profiling differentially expressed proteins between Chinese left- and right-sided colon cancers.

Hong Shen,Jinlin Huang,Haiping Pei,Shan Zeng,Yiming Tao,Liangfang Shen,Liang Zeng,Hong Zhu

DOI: https://doi.org/10.1111/cas.12029

IF: 5.7

2013-01-01

Cancer Science

Abstract:The aim of the present study is to profile differentially expressed protein markers between left-sided colon cancer (LSCC) and right-sided colon cancer (RSCC). Fresh tumor tissue samples from LSCC (n = 7) and RSCC (n = 7) groups were analyzed by two-dimensional electrophoresis coupled with MALDI-TOF-MS, followed by Western blotting. In 50 paraffin embedded samples from each group, levels of four differentially expressed proteins (identified by proteomics analysis) were measured by tissue microarray with immunohistochemistry staining to compare the different protein markers between LSCC and RSCC. Sixteen proteins were found to be differentially expressed between LSCC and RSCC. Ten proteins including HSP-60 and PDIA1 were identified to be highly expressed in LSCC (P < 0.01 or P < 0.05), while the expression of six proteins including EEF1D and HSP-27 were higher in RSCC (P < 0.01 or P < 0.05). Virtually all of the indentified proteins were involved in cellular energy metabolism, protein folding/unfolding, and/or oxidative stress. Human colon tumors at various locations have different proteomic biomarkers. Differentially expressed proteins associated with energy metabolism, protein folding/unfolding and oxidative stress contribute to different tumorigenesis, tumor progression, and prognosis between left- and right-sided colon cancer. (Cancer Sci 2013; 104: 141135)
Abstract A21: Proteomic Profiling to Elucidate Intratumoral Heterogeneity and Cancer Evolution in Lung Cancer

Charlotte Lee,Hua-Jun Wu,Andre L. Moreira,Erin H. Seeley,Callee Walsh,Robert J. Downey,Franziska Michor

DOI: https://doi.org/10.1158/1535-7163.targ-15-a21

2015-01-01

Molecular Cancer Therapeutics

Abstract:Tumors often display a high degree of intratumoral heterogeneity as manifested by dynamic changes in gene expression, protein expression, and on gross examination of histology, among many other features. Clinically, this underlying heterogeneity can drive tumor evolution and progression towards a more aggressive neoplastic state and a worse prognosis for patients; therefore, identifying the diverse composition of a tumor for early risk stratification is of critical importance. To elucidate intratumoral heterogeneity and intracellular hierarchy in a novel manner, we first conducted a low-cost quantitative proteomics analysis using MALDI-TOF mass spectrometry on over 1900 samples from different histological regions of individual tumors from 35 lung cancer patients, as well as from 3 mesenchymal stem cell samples. The histologies identified were acinar, basal cells, bronchial epithelium, lepidic, complex gland, micropapillary, near tumor normal, normal alveolar, papillary, papillary lepidic, papillary mucinous, and solid. Patient-specific information including survival status, sex, age, smoking status, SUV by FDG-PET scan, tumor size, EGFR, KRAS, and ERCC1 mutation status, among other variables was obtained. We then compared the proteomes derived from each tumor to the stem cell proteomes, and using computational strategies, mapped the distance of each histological sample from the mesenchymal stem cell state; using clustering techniques, we organized the major histological subtypes into a phylogenetic tree from stem cells to normal lung. We hypothesized that by applying and improving upon map of tumor evolution based on the distance of each individual histological sample from a stem cell state. Apart from liquid tumors, there have thus far been limited studies on the prognostic significance of different subclones in solid tumors, and therefore we treated each histological sample as a subclone within each patient. We also aimed to identify survival-associated subclones and prognostic molecular signatures across combinations of subclones. Identifying these subclones may provide insight into malignant micrometastases to other organs. Using co-expression network analysis, we further pinpointed distinctive significantly dysregulated co-regulatory protein networks within each histological subtype. Based on these networks, we sought to identify important hub proteins within each histology. Ultimately, using proteomic profiling in solid tumors can be a novel approach in functionally characterizing intratumoral heterogeneity, and may allow for a more robust analysis of the diverse molecular expression of single tumor samples. Our results may help inform the field of targeted broad-scale proteomics profiling for therapeutic use. Citation Format: Charlotte Lee, Hua-Jun Wu, Andre L. Moreira, Erin H. Seeley, Callee Walsh, Robert J. Downey, Franziska Michor. Proteomic profiling to elucidate intratumoral heterogeneity and cancer evolution in lung cancer. [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2015 Nov 5-9; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2015;14(12 Suppl 2):Abstract nr A21.
Comparative Proteome Analysis of Three Mouse Lung Adenocarcinoma CMT Cell Lines with Different Metastatic Potential by Two‐dimensional Gel Electrophoresis and Mass Spectrometry

Kelan Zhang,Krzysztof Wrzesinski,J. Fey Stephen,Peter Mose Larsen,Xumin Zhang,Peter Roepstorff

DOI: https://doi.org/10.1002/pmic.200800299

2008-01-01

PROTEOMICS

Abstract:Metastasis is a lethal attribute of a cancer and presents a continuing therapeutic challenge. Metastasis is a highly complex process and more knowledge about the mechanisms behind metastasis is highly desirable. Isogenic CMT cell lines were selected from a spontaneous mouse lung adenocarcinoma and characterized in vivo to have different metastatic potential. In this study, the comprehensive protein expression profiles of three of these CMT cell lines at passage 5, 15 and 35 were analyzed by 2-DE separation followed by MS identification. As a result, 82 and 40 unique proteins were found to be significantly up- or down-regulated between cell lines with different metastatic potential at passages 5 and 15, respectively. These proteins were identified by MS and most of them have previously been reported to be related to cancer development and/or metastasis. Bioinformatics analysis indicated that several of the proteins were involved in proteasome, cell-cycle and cell-communication pathways. Among them, some keratins, 14-3-3 proteins and 26S proteasome proteins were identified and their aberrant expression may be directly or indirectly involved in cancer development and metastasis. In conclusion, our comprehensive 2-DE-based proteomics studies revealed some candidate proteins, protein families and signaling pathways, which might be important in cancer development and metastasis.
Integrative Proteomic Characterization of Human Lung Adenocarcinoma

Jun-Yu Xu,Chunchao Zhang,Xiang Wang,Linhui Zhai,Yiming Ma,Yousheng Mao,Kun Qian,Changqing Sun,Zhiwei Liu,Shangwen Jiang,Minghui Wang,Lin Feng,Lei Zhao,Ping Liu,Bo Wang,Xin Zhao,Hui Xie,Xiaoyun Yang,Liyuan Zhao,Yafei Chang,Jingya Jia,Xijun Wang,Yimin Zhang,Yaru Wang,Yikun Yang,Zhixiang Wu,Longhai Yang,Bin Liu,Teng Zhao,Shengguo Ren,Aihua Sun,Yang Zhao,Wantao Ying,Fei Wang,Guangshun Wang,Yi Zhang,Shujun Cheng,Jun Qin,Xiaohong Qian,Yi Wang,Jing Li,Fuchu He,Ting Xiao,Minjia Tan

DOI: https://doi.org/10.1016/j.cell.2020.05.043

IF: 64.5

2020-07-01

Cell

Abstract:Genomic studies of lung adenocarcinoma (LUAD) have advanced our understanding of the disease's biology and accelerated targeted therapy. However, the proteomic characteristics of LUAD remain poorly understood. We carried out a comprehensive proteomics analysis of 103 cases of LUAD in Chinese patients. Integrative analysis of proteome, phosphoproteome, transcriptome, and whole-exome sequencing data revealed cancer-associated characteristics, such as tumor-associated protein variants, distinct proteomics features, and clinical outcomes in patients at an early stage or with EGFR and TP53 mutations. Proteome-based stratification of LUAD revealed three subtypes (S-I, S-II, and S-III) related to different clinical and molecular features. Further, we nominated potential drug targets and validated the plasma protein level of HSP 90β as a potential prognostic biomarker for LUAD in an independent cohort. Our integrative proteomics analysis enables a more comprehensive understanding of the molecular landscape of LUAD and offers an opportunity for more precise diagnosis and treatment.

cell biology,biochemistry & molecular biology
Comparative Proteomic Analysis of Non-small-cell Lung Cancer and Normal Controls Using Serum Label-Free Quantitative Shotgun Technology

Jun Pan,Hai-Quan Chen,Yi-Hua Sun,Jun-Hua Zhang,Xiao-Yang Luo

DOI: https://doi.org/10.1007/s00408-008-9093-7

2008-01-01

Lung

Abstract:The aim of this study was to distinguish non-small-cell lung cancer from normal controls and explore the new potential biomarkers of lung cancer by serum proteomics technology. Label-free quantitative liquid chromatography tandem mass spectrometry (1D-LC/MS/MS) analysis was performed on eight non-small-cell lung cancer (NSCLC) serum samples and eight normal controls. The proteomic data we obtained was analyzed by normalized, randomly paired t test and integrated bioinformatic methods, including hierarchical clustering analysis, principal-component analysis, and support vector machine. We obtained 931 proteins with at least two peptides identified from the 16 serum samples, and 62 proteins were differentially expressed between non-small-cell lung cancer patients and normal controls. There were 16 proteins expressed much higher in the lung cancer group than in the controls. Two hundred eight proteins were shared in all 16 serum samples. Through hierarchical clustering analysis and principal-component analysis based on the 62 differentially expressed proteins, we could distinguish non-small-cell lung cancer from the normal controls. The prediction accuracy of non-small-cell lung cancer analyzed by the support vector machine algorithm based on 208 proteins which were shared in all serum samples is 93.75%. Protein expression patterns have changed in the serum of non-small-cell lung cancer patients. Label-free quantitative LC/MS/MS may be a good method to improve the diagnostic accuracy for lung cancer and it can help in discovering the new biomarkers.
[Differential Analysis of Two-Dimension Gel Electrophoresis Profiles of Human Lung Squamous Carcinoma and Tumor-Adjacent Tissue].

Cui Li,Zhu-Chu Chen,Zhi-Qiang Xiao,Xiao-Ying Wu,Xian-Quan Zhan,Mao-Yu Li,Xue-Ping Feng,Xiao-Peng Zhang,Jian-Ling Li,Ping Chen,Song-Ping Liang

DOI: https://doi.org/10.3969/j.issn.1000-467x.2004.01.005

2004-01-01

Abstract:BACKGROUND & OBJECTIVE:Carcinogenesis of lung squamous carcinoma is a complex process involving multiple events and steps. Though some molecular pathogenesis studies on human lung cancer have been undertaken successfully in gene (DNA) and transcription (mRNA) levels, the carcinogenic mechanism is still unclear. At present, there is no special molecular marker for early-stage diagnosis and prognosis evaluation. The objective of this study was to establish two-dimensional electrophoresis profiles with high resolution and reproducibility from human lung squamous carcinoma tissue and paired normal tumor-adjacent bronchial epithelial tissue, and to identify differential expression proteins.METHODS:The total proteins of human lung squamous carcinoma tissue and paired normal tumor-adjacent bronchial epithelial tissue were separated by immobilized pH gradient (IPG)-based two-dimensional gel electrophoresis (2-DE). The differential expression proteins were analyzed using image analysis software, then identified using mass spectrometry and database searching.RESULTS:(1) For tumor tissues, the average protein spots of 3 gels were 1349+/-67; and 1235+/-48 spots were matched with the average matching rate of 91.5%. For control, the average protein spots of 3 gels were 1297+/-73; and 1183+/-56 spots were matched with the average matching rate of 91.2%. The average position deviation of matched spots was 0.873+/-0.125 mm in IEF direction, and 1.025+/-0.213 mm in SDS-PAGE direction. (2) A total of 1069+/-45 spots were matched between the electrophoretic maps of 15 human lung squamous carcinoma tissue and paired normal tumor-adjacent bronchial epithelial tissue. Forty differential proteins were identified by peptide mass fingerprint(PMF), some proteins were the products of oncogenes, and the others involve in the regulation of cell cycle and signal transduction.CONCLUSION:In this study, the well-resolved, reproducible 2-DE patterns of human lung squamous carcinoma and adjacent normal bronchial epithelial tissues were established and certain differential proteins were characterized. These data will be helpful for screening the biomarker to further study on human lung squamous carcinoma.
Proteomics analysis of stage-specific proteins expressed in human squamous cell lung carcinoma tissues.

Bin Deng,Nengsheng Ye,Guoan Luo,Xian Chen,Yiming Wang

DOI: https://doi.org/10.3233/cbm-2005-1603

2005-01-01

Abstract:There is a growing interest in applying proteomics to gain insight into the mechanism of tumorigenesis, develop new markers for molecular diagnosis and accelerate drug development. In an attempt to find new stage-specific tumor markers, patients suffering from squamous cell lung carcinomas (SQCLC) at different pathologic stages have been selected to achieve differential protein expression patterns. Two-dimensional polyacrylamide gel electrophoresis (2-DE) profiles of human SQCLC and normal tissue were compared. Differential protein spots were identified with peptide mass fingerprinting (PMF) based on matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS) and database searching. A total of 63 unique proteins were identified in this experiment. Among them, peroxiredoxin 1 (PRDX1) expression level was significantly increased from stage I to III, and had a slight decrease at stage IV; whereas, a lasting decrease in the expression level of tropomyosins 3 (TPM3), was observed with the malignant progression from I stage to IV stage. These results provide further insight into malignant transformation in SQCLC and proteins may serve as new biomarkers for early diagnosis.

Practical aspects of multiple sequence alignment.

[Use of Laser Capture Microdissection and Surface-Enhanced Laser Desorption Ionization Time-of-flight Mass Spectrometry to Screen Differential Proteins in Lung Adenocarcinoma and Lung Squamous Carcinoma].

Proteomic and Phosphoproteomic Maps of Lung Squamous Cell Carcinoma from Chinese Patients.

Interactive Verification Analysis of Multiple Sequencing Data for Identifying Potential Biomarker of Lung Adenocarcinoma

Identification of Key Genes and Evaluation of Clinical Outcomes in Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis

Relative Protein Quantification and Accessible Biology in Lung Tumor Proteomes from Four LC-MS/MS Discovery Platforms

Proteomic profiles of human lung adeno and squamous cell carcinoma using super-SILAC and label-free quantification approaches

A Bird's Eye View of Quantitative Proteome of Tumor Tissues from Lung Cancer Patients by a High Precision Mass Spectrometry Method

Comparative proteome analysis of human lung squamous cell carcinoma

Differential mitochondrial proteome analysis of human lung adenocarcinoma and normal bronchial epithelium cell lines using quantitative mass spectrometry

Profiling differentially expressed proteins in lung adenocarcinoma by label-free proteomics

Abstraction of nano copper in a room temperature ionic liquid

Proteomic analysis enables distinction of early- versus advanced-stage lung adenocarcinomas

Aberrant Expression of Proteins Involved in Signal Transduction and DNA Repair Pathways in Lung Cancer and Their Association with Clinical Parameters.

Comparative proteomic study for profiling differentially expressed proteins between Chinese left- and right-sided colon cancers.

Abstract A21: Proteomic Profiling to Elucidate Intratumoral Heterogeneity and Cancer Evolution in Lung Cancer

Comparative Proteome Analysis of Three Mouse Lung Adenocarcinoma CMT Cell Lines with Different Metastatic Potential by Two‐dimensional Gel Electrophoresis and Mass Spectrometry

Integrative Proteomic Characterization of Human Lung Adenocarcinoma

Comparative Proteomic Analysis of Non-small-cell Lung Cancer and Normal Controls Using Serum Label-Free Quantitative Shotgun Technology

[Differential Analysis of Two-Dimension Gel Electrophoresis Profiles of Human Lung Squamous Carcinoma and Tumor-Adjacent Tissue].

Proteomics analysis of stage-specific proteins expressed in human squamous cell lung carcinoma tissues.